{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:29:46Z","timestamp":1778200186138,"version":"3.51.4"},"reference-count":182,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.vaccine.2004.12.029","type":"journal-article","created":{"date-parts":[[2005,2,18]],"date-time":"2005-02-18T12:50:59Z","timestamp":1108731059000},"page":"3369-3385","source":"Crossref","is-referenced-by-count":66,"title":["Considerations for development of whole cell bacterial vaccines to prevent diarrheal diseases in children in developing countries"],"prefix":"10.1016","volume":"23","author":[{"given":"Richard I.","family":"Walker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2004.12.029_bib1","unstructured":"World Health Organization. Development of vaccines against cholera and diarrhea due to enterotoxigenic Escherichia coli: memorandum from a WHO meeting. Bull WHO 1990;68:303\u201312."},{"key":"10.1016\/j.vaccine.2004.12.029_bib2","first-page":"705","article-title":"The magnitude of the global problem of diarrhoeal disease: a ten-year update","volume":"70","author":"Berne","year":"1992","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2004.12.029_bib3","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.bpg.2003.11.004","article-title":"Progress in enteric vaccine development","volume":"18","author":"Svennerholm","year":"2004","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.vaccine.2004.12.029_bib4","unstructured":"World Health Organization. Programme for control of diarrhoeal diseases: ninth programme report 1992\u20131993. Geneva: World health Organization; 1994."},{"key":"10.1016\/j.vaccine.2004.12.029_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0924-8579(99)00149-1","article-title":"Diarrhoea: a significant worldwide problem","volume":"14","author":"Farthing","year":"2000","journal-title":"Intern J Antimicrobial Agents"},{"issue":"12","key":"10.1016\/j.vaccine.2004.12.029_bib6","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.1128\/AEM.66.12.5406-5409.2000","article-title":"Long-term shifts in patterns of antibiotic resistance in enteric bacteria","volume":"66","author":"Houndt","year":"2000","journal-title":"Appl Environ Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2004.12.029_bib7","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/ije\/30.6.1457","article-title":"Early childhood diarrhea and helminthiases associate with long-term linear growth faltering","volume":"30","author":"Moore","year":"2001","journal-title":"Int J Epidemiol"},{"issue":"5","key":"10.1016\/j.vaccine.2004.12.029_bib8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0924-8579(02)00208-X","article-title":"Epidemiology of bacterial resistance in gastro-intestinal pathogens in a tropical area","volume":"20","author":"Bonfiglio","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.vaccine.2004.12.029_bib9","unstructured":"Institute of Medicine, New Vaccine Development, Establishing Properties: vol. II. Diseases of Importance in Developing Countries. Washington DC: National Academy Press 1986;8(2):131\u201335."},{"key":"10.1016\/j.vaccine.2004.12.029_bib10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-1-4615-4143-1_8","article-title":"Mechanisms and impact of enteric infections","volume":"473","author":"Guerrant","year":"1999","journal-title":"Adv Exp Med Biol"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2004.12.029_bib11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4269\/ajtmh.1992.47.28","article-title":"Diarrhea as a cause and effect of malnutrition: diarrhea prevents catch-up growth and malnutrition increases diarrhea frequency and duration","volume":"47","author":"Guerrant","year":"1992","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.vaccine.2004.12.029_bib12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0188-4409(02)00379-X","article-title":"Lima: magnitude and impact of diarrheal diseases","volume":"33","author":"Guerrant","year":"2002","journal-title":"Arch Med Res"},{"key":"10.1016\/j.vaccine.2004.12.029_bib13","series-title":"Nelson textbook of pediatrics","author":"Behrman","year":"1987"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2004.12.029_bib14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/clinids\/8.Supplement_2.S109","article-title":"Travelers\u2019 diarrhea: National Institutes of Health consensus development conference. Introduction","volume":"8","author":"Gorbach","year":"1986","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2004.12.029_bib15","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1056\/NEJM199111143252006","article-title":"Diarrheal disease during Operation Desert Sheild: a major cause of infectious disease morbidity among United States military personnel","volume":"325","author":"Hyams","year":"1991","journal-title":"NEJM"},{"key":"10.1016\/j.vaccine.2004.12.029_bib16","first-page":"15","article-title":"Prospects and problems for development of a vaccine against diarrhea caused by Campylobacter","volume":"3","author":"Haberberger","year":"1994","journal-title":"Vaccine Res"},{"key":"10.1016\/j.vaccine.2004.12.029_bib17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/bmb\/62.1.113","article-title":"Vaccines against human entric bacterial pathogens","volume":"62","author":"Dougan","year":"2002","journal-title":"Br Med Bull"},{"issue":"8425","key":"10.1016\/j.vaccine.2004.12.029_bib18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0140-6736(85)91397-2","article-title":"Polymicrobial aetiology of travellers\u2019 diarrhoea","volume":"1","author":"Taylor","year":"1985","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2004.12.029_bib19","first-page":"164","article-title":"Acute Campylobacter jejuni enteritis in 385 hospitalised patients","volume":"40","author":"Bichile","year":"1992","journal-title":"J Assoc Phys India"},{"key":"10.1016\/j.vaccine.2004.12.029_bib20","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/0140-6736(91)92590-X","article-title":"Prevention of travelers diarrhoea by oral B-subunit\/whole cell cholera vaccine","volume":"338","author":"Petola","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2004.12.029_bib21","series-title":"Campylobacter jejuni. Current status and future trends","first-page":"1","year":"1992"},{"key":"10.1016\/j.vaccine.2004.12.029_bib22","series-title":"Bacterial infections of humans. Epidemiology and control","first-page":"151","article-title":"Campylobacter infections","author":"Taylor","year":"1991"},{"key":"10.1016\/j.vaccine.2004.12.029_bib23","series-title":"Foodborne bacterial pathogens","first-page":"71","article-title":"Campylobacter jejuni","author":"Stern","year":"1989"},{"issue":"2","key":"10.1016\/j.vaccine.2004.12.029_bib24","first-page":"186","article-title":"Do you have Campylobacter in your future?","volume":"161","author":"Mishu","year":"1994","journal-title":"West J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2004.12.029_bib25","first-page":"148","article-title":"Clinical aspects of Campylobacter jejuni infection in adults","volume":"161","author":"Peterson","year":"1994","journal-title":"West J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2004.12.029_bib26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ana.410330304","article-title":"Campylobacter jejuni strains from patients with Guillain\u2013Barre syndrome belong mostly to Penner serogroup 19 and contain beta-N-acetylglucosamine residues","volume":"33","author":"Kuroki","year":"1993","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.vaccine.2004.12.029_bib27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/clinids\/17.1.104","article-title":"Role of infection due to Campylobacter jejuni in the initiation of Guillain\u2013Barre syndrome","volume":"17","author":"Mishu","year":"1993","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2004.12.029_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410390105","article-title":"Pathology of motor-sensory axonal Guillain\u2013Barre syndrome","volume":"39","author":"Griffin","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.vaccine.2004.12.029_bib29","first-page":"651","article-title":"Global burden of shigella infections: implications for vaccine development and implementation","volume":"77","author":"Kotloff","year":"1999","journal-title":"Bull WHO"},{"issue":"4","key":"10.1016\/j.vaccine.2004.12.029_bib30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/clinids\/13.Supplement_4.S319","article-title":"Potentially lethal complications of shigellosis","volume":"13","author":"Bennish","year":"1991","journal-title":"Rev Infect Dis"},{"issue":"Suppl. 4","key":"10.1016\/j.vaccine.2004.12.029_bib31","doi-asserted-by":"crossref","first-page":"S226","DOI":"10.1093\/clinids\/13.Supplement_4.S226","article-title":"Epidemiologic aspects of shigellosis and other causes of dysentary in Thailand","volume":"13","author":"Taylor","year":"1991","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2004.12.029_bib32","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0140-6736(88)92669-4","article-title":"Diagnosis and management of dysentery by community health workers","volume":"ii","author":"Ronsmans","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2004.12.029_bib33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/infdis\/122.3.181","article-title":"Epidemic shiga bacillus dysentary in Central America. II. Epidemiologic studies in","volume":"122","author":"Gangarosa","year":"1970","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2004.12.029_bib34","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0140-6736(81)91277-0","article-title":"Plasmid characterisation in the investigation of an epidemic caused by multiply resistant Shigella dysenteriae type 1","volume":"ii","author":"Frost","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2004.12.029_bib35","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/infdis\/169.5.1035","article-title":"Epidemic Shigella dysenteriae type 1 in Burundi: pan resistance and implications for prevention","volume":"169","author":"Ries","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2004.12.029_bib36","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/S0140-6736(84)91948-2","article-title":"Epidemic bacillary dysentery in West Bengal, India","volume":"I","author":"Pal","year":"1984","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2004.12.029_bib37","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/clinids\/8.Supplement_2.S136","article-title":"Etiology and epidemiology of travelers\u2019 diarrhea in Asia","volume":"8","author":"Taylor","year":"1986","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2004.12.029_bib38","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/02724936.1993.11747649","article-title":"A review of bacterial resistance to antimicrobial agents in tropical countries","volume":"13","author":"Shears","year":"1993","journal-title":"Ann Trop Paediatr"},{"key":"10.1016\/j.vaccine.2004.12.029_bib39","first-page":"3","article-title":"An outbreak of dysentery in a day nursery and a school","volume":"46","author":"Packer","year":"1983","journal-title":"Commun Dis Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2004.12.029_bib40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1017\/S0950268800057642","article-title":"An outbreak of diarrhoeal disease attributed to Shigella sonnei","volume":"112","author":"Samonis","year":"1994","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2004.12.029_bib41","series-title":"Development of vaccines and drugs against diarrhea","first-page":"23","article-title":"The epidemiology of cholera and enterotoxigenic E. coli diarrheal disease","author":"Black","year":"1986"},{"key":"10.1016\/j.vaccine.2004.12.029_bib42","series-title":"Vaccines","first-page":"639","article-title":"Cholera vaccines","author":"Sack","year":"1999"},{"key":"10.1016\/j.vaccine.2004.12.029_bib43","unstructured":"World Health Organization. Cholera vaccines. WHO position paper. Week Epidemiol Res 2001;76:117\u201324."},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2004.12.029_bib44","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0264-410X(00)00264-4","article-title":"Microencapsulated enterotoxigenic Escherichia and detached fimbriae for peroral vaccination of pigs","volume":"19","author":"Felder","year":"2000","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2004.12.029_bib45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0264-410X(93)90013-N","article-title":"Preclinical evaluation of microencapsulated CFA\/II oral vaccine against enterotoxigenic E. coli","volume":"11","author":"Reid","year":"1993","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2004.12.029_bib46","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1128\/IAI.69.3.1351-1357.2001","article-title":"Safety and immunogenicity of improved Shigella O-specific polysaccharide protein conjugate vaccines in adults in Israel","volume":"69","author":"Passwell","year":"2001","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2004.12.029_bib47","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1086\/314759","article-title":"Safety and immunogenicty of Shigella sonnei and Shigella flexneri 2a O specific polysaccharide conjugates in children","volume":"179","author":"Ashkenazi","year":"1999","journal-title":"J Infect Dis"},{"issue":"5)","key":"10.1016\/j.vaccine.2004.12.029_bib48","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1023\/A:1020393426750","article-title":"A functional antigen in a practical crop: LT-B producing maize protects mice against Escherichia coli heat labile enterotoxin (LT) and cholera toxin (CT)","volume":"11","author":"Chikwamba","year":"2002","journal-title":"Transgenic Res"},{"issue":"11","key":"10.1016\/j.vaccine.2004.12.029_bib49","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1073\/pnas.93.11.5335","article-title":"Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice","volume":"93","author":"Mason","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.vaccine.2004.12.029_bib50","first-page":"190","article-title":"Edible vaccines","volume":"112","author":"Artnzen","year":"1997","journal-title":"Pub Health Rep"},{"issue":"12","key":"10.1016\/j.vaccine.2004.12.029_bib51","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/82225","article-title":"Transcutaneous immunization: a human vaccine delivery strategy using a patch","volume":"6","author":"Glenn","year":"2000","journal-title":"Nat Med"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2004.12.029_bib52","first-page":"47","article-title":"Development of oral vaccines against cholera and enterotoxigenic Esherichia coli diarrhea","volume":"76","author":"Holmgren","year":"1990","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2004.12.029_bib53","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00006454-200204000-00012","article-title":"Introductory evaluation of an oral, killed whole cell enterotoxigenic Esherichia coli plus cholera toxin B-subunit vaccine in Egyptian infants","volume":"21","author":"Savarino","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2004.12.029_bib54","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1128\/IAI.67.2.782-788.1999","article-title":"Strategy for cross-protection among Shigella flexneri serotypes","volume":"67","author":"Noriega","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.12.029_bib55","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/0264-410X(89)90228-4","article-title":"Development of oral vaccines against enterotoxigenic Escherichia coli diarrhoea","volume":"7","author":"Svennerholm","year":"1989","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2004.12.029_bib56","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1128\/IAI.38.1.74-79.1982","article-title":"Synergistic protective effect of antibodies against Escherichia coli entertoxin and colonization factor antigens","volume":"38","author":"Ahren","year":"1982","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2004.12.029_bib57","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1128\/IAI.70.4.1965-1970.2002","article-title":"Randomized, controlled human challenge study of the safety, immunogenicty, and protective efficacy of a single dose of Peru-15, a live attenuated oral cholera vaccine","volume":"70","author":"Cohen","year":"2002","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2004.12.029_bib58","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1128\/IAI.70.6.2950-2958.2002","article-title":"Construction, characterization, and animal testing of WRSd1, a Shigella dysenteriae 1 vaccine","volume":"70","author":"Venkatesan","year":"2002","journal-title":"J Infect Immundkjdot"},{"key":"10.1016\/j.vaccine.2004.12.029_bib59","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0140-6736(98)09001-1","article-title":"Typhoid fever in children less than 5 years","volume":"354","author":"Sinha","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2004.12.029_bib60","first-page":"783","article-title":"Norwalk group of viruses","volume":"2","author":"Kapikian","year":"1996"},{"issue":"20","key":"10.1016\/j.vaccine.2004.12.029_bib61","doi-asserted-by":"crossref","first-page":"9713","DOI":"10.1128\/JVI.75.20.9713-9722.2001","article-title":"Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses","volume":"75","author":"Guerreo","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2004.12.029_bib62","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1128\/JVI.72.2.1345-1353.1998","article-title":"Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice","volume":"72","author":"Ball","year":"1998","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2004.12.029_bib63","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0016-5085(99)70548-2","article-title":"Recombinant Norwalk virus-like particles given orally to volunteers: phase I study","volume":"2117","author":"Ball","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.vaccine.2004.12.029_bib64","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1016\/S0264-410X(02)00315-8","article-title":"Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses","volume":"20","author":"Choi","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.12.029_bib65","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1016\/S0264-410X(00)00543-0","article-title":"Immune responses and protection obtained with rotavirus VP6 DNA vaccines given by intramuscular injection","volume":"19","author":"Yang","year":"2001","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2004.12.029_bib66","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1128\/IAI.70.3.1056-1068.2002","article-title":"Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli","volume":"70","author":"Yu","year":"2002","journal-title":"Infect Imm"},{"key":"10.1016\/j.vaccine.2004.12.029_bib67","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1016\/S0264-410X(02)00208-6","article-title":"Comparison of mucosal and systemic humoral immune responses after transcutaneous and oral immunization strategies","volume":"20","author":"John","year":"2002","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2004.12.029_bib68","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1286-4579(03)00112-6","article-title":"Helicobacter in the developing world","volume":"5","author":"Frenck","year":"2003","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2004.12.029_bib69","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1086\/345762","article-title":"Association between Helicobacter pylori infection and increased risk of typhoid fever","volume":"186","author":"Bhan","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2004.12.029_bib70","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0264-410X(94)90293-3","article-title":"Influence of strain viability and antigen dose on the use of attenuated mutants of Salmonella as vaccine carriers","volume":"12","author":"C\u00e1rdenas","year":"1994","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2004.12.029_bib71","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1128\/IAI.69.3.1389-1393.2001","article-title":"Oral administration of formaldehyde-killed recombinant bacteria expressing a mimic of the shiga toxin receptor protects mice from fatal challenge with shiga-toxigenic Escherichia coli","volume":"69","author":"Paton","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.12.029_bib72","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0168-1656(99)00144-3","article-title":"Extended recombinant bacterial ghost system","volume":"73","author":"Lubitz","year":"1999","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2004.12.029_bib73","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/0264-410X(94)90249-6","article-title":"Production of Vibrio cholerae ghosts (VCG) by expression of a cloned phage lysis gene: potential for vaccine development","volume":"12","author":"Eko","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.12.029_bib74","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0168-1656(00)00298-4","article-title":"Activation, stimulation, and uptake of bacterial ghosts in antigen presenting cells","volume":"83","author":"Haselberger","year":"2000","journal-title":"J Biotech"},{"key":"10.1016\/j.vaccine.2004.12.029_bib75","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1586\/14760584.2.1.45","article-title":"Bacterial ghosts as carrier and targeting systems for mucosal antigen delivery","volume":"2","author":"Jalava","year":"2003","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2004.12.029_bib76","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1016\/S0264-410X(03)00388-8","article-title":"Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits","volume":"21","author":"Eko","year":"2003","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2004.12.029_bib77","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/S0264-410X(94)80061-4","article-title":"Immunogenicity of Vibrio cholerae ghosts following intraperitoneal immunization of mice","volume":"12","author":"Eko","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.12.029_bib78","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/0264-410X(93)90101-3","article-title":"Killed Campylobacter elicits immune response and protection when administered with an oral adjuvant","volume":"11","author":"Rollwagen","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.12.029_bib79","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1128\/IAI.63.9.3731-3735.1995","article-title":"Immunogenicity and protective efficacy of a prototype Campylobacter killed whole cell vaccine in mice","volume":"63","author":"Baqar","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.12.029_bib80","unstructured":"Tribble D, Baqar S, Faix D, Liss A, Nielsen R, Porter C, et al. Modified Escherichia coli heat-labile toxin (LT[R192G]) adjuvant dose-range study of an oral, inactivated whole cell Campylobacter (CWC) vaccine in volunteers. Modern Vaccines, Adjuvants and Delivery System. Dublin, Ireland: 4\u20136 June 2004."},{"key":"10.1016\/j.vaccine.2004.12.029_bib81","doi-asserted-by":"crossref","first-page":"5841","DOI":"10.1128\/IAI.67.11.5841-5847.1999","article-title":"Native and mutant forms of cholera toxin and heat-labile enterotoxin effectively enhance protective efficacy of live attenuated and heat-killed Shigella vaccines","volume":"67","author":"Hartman","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.12.029_bib82","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1651-2227.1999.tb01075.x","article-title":"Killed oral Shigella vaccine made from Shigella flexneri 2a protects against challenge in a rabbit model of shigellosis","volume":"88","author":"Chakrabarti","year":"1999","journal-title":"Acta Paediatr"},{"issue":"7","key":"10.1016\/j.vaccine.2004.12.029_bib83","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1128\/IAI.68.7.4349-4353.2000","article-title":"Adjuvant activity of a nontoxic mutant of Escherichia coli heat labile enterotoxin on systemic and mucosal immune responses elicited against a heterologous antigen carried by a live Salmonella enterica serovar Typhimurium vaccine strain","volume":"68","author":"Guillobel","year":"2000","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2004.12.029_bib84","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1128\/IAI.69.6.3581-3590.2001","article-title":"Safety and immunogenicity of oral inactivated whole cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection","volume":"69","author":"Kotloff","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.12.029_bib85","unstructured":"Tribble DR, Baqar S, Oplinger ML, Bourgeois AL, Clements JD, Pazzaglia G, et al. Safety and immunogenicity of an oral, inactivated whole cell Campylobacter vaccine co-administered with modified Escherichia coli heat-labile enterotoxin (LTR1926) adjuvant in volunteers. Interscience Conference on Antimicrobial Agents Chemotherapy. Toronto, Canada; 1997."},{"issue":"2","key":"10.1016\/j.vaccine.2004.12.029_bib86","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0966-842X(98)01438-3","article-title":"CpG DNA: a novel immunomodulator","volume":"7","author":"Krieg","year":"1999","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2004.12.029_bib87","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1128\/IAI.71.1.40-46.2003","article-title":"Mucosal immunization with Helicobacter, CpG DNA, and cholera toxin is protective","volume":"21","author":"Jiang","year":"2003","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2004.12.029_bib88","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0022-3476(99)70086-7","article-title":"Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials","volume":"135","author":"Bhutta","year":"1999","journal-title":"J Pediatr"},{"issue":"7","key":"10.1016\/j.vaccine.2004.12.029_bib89","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1128\/IAI.71.7.3909-3913.2003","article-title":"Intestinal and systemic immune responses to an oral cholera toxoid B-subunit whole cell vaccine administered during zinc supplementation","volume":"71","author":"Karlsen","year":"2003","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2004.12.029_bib90","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/368132","article-title":"Supplementation with zinc, but not Vitamin A, improves the seroconversion to vibriocidal antibody in children given an oral cholera vaccine","volume":"187","author":"Albert","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2004.12.029_bib91","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0169-409X(01)00163-6","article-title":"Bacteria-derived particles as ajuvants for non-replacing nasal vaccines","volume":"51","author":"Haneberg","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2004.12.029_bib92","first-page":"467","article-title":"Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR","volume":"2","author":"Levine","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2004.12.029_bib93","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0264-410X(90)90012-B","article-title":"Randomized double blind placebo controlled trial to evaluate the safety and immunogenicity of the live oral cholera vaccine strain CVD 103HgR in Swiss adults","volume":"8","author":"Cryz","year":"1990","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2004.12.029_bib94","first-page":"41","article-title":"Virulence and immunogenicity of Salmonella typhimurium rough mutants","volume":"38","author":"Germanier","year":"1972","journal-title":"Pathol Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2004.12.029_bib95","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/infdis\/159.4.766","article-title":"Comparative efficacy of two, three, or four doses of TY21a live oral typhoid vaccine in enteric-coated capsules: a field trial in an endemic area","volume":"59","author":"Ferreccio","year":"1989","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2004.12.029_bib96","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0264-410X(90)90088-4","article-title":"Antibody-secreting cells in the evaluation of the immunogenicity of an oral vaccine","volume":"8","author":"Kantele","year":"1990","journal-title":"Vaccine"},{"issue":"6673","key":"10.1016\/j.vaccine.2004.12.029_bib97","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.vaccine.2004.12.029_bib98","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1084\/jem.179.4.1331","article-title":"Rapid dendritic cell recruitment is a hallmark of the acute inflammatory response at mucosal surfaces","volume":"179","author":"McWilliam","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2004.12.029_bib99","series-title":"Proceedings of the Seventh International Congress Mucosal Immunology","first-page":"23","article-title":"Comparison of IgA antibodies in vaginal and rectal fluids, serum and saliva following immunization of genital and gut-associated lymphoid tissue","author":"Bergmeir","year":"1992"},{"key":"10.1016\/j.vaccine.2004.12.029_bib100","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.4049\/jimmunol.139.10.3484","article-title":"Combined oral\/nasal immunization protects mice from Sendai virus infection","volume":"139","author":"Nedrud","year":"1987","journal-title":"J Immun"},{"key":"10.1016\/j.vaccine.2004.12.029_bib101","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1128\/IAI.62.1.15-23.1994","article-title":"Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces","volume":"62","author":"Haneberg","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.12.029_bib102","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1099\/0022-1317-49-2-157","article-title":"A nasal whole cell pertussis vaccine can induce specific systemic and cross-reactive mucosal antibody responses in human volunteers","volume":"49","author":"Berstad","year":"2000","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2004.12.029_bib103","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0264-410X(94)90112-0","article-title":"New strategies for using mucosal vaccination to achieve more effective immunization","volume":"12","author":"Walker","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.12.029_bib104","first-page":"189","article-title":"The number and distribution of lymphoid follicles in the human large intestine","volume":"149","author":"Langman","year":"1986","journal-title":"J Anat"},{"issue":"6","key":"10.1016\/j.vaccine.2004.12.029_bib105","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.4049\/jimmunol.102.6.1423","article-title":"Distribution of poliovirus antibody in serum, nasopharynx and alimentary tract following segmental immunization of lower alimentary tract with poliovaccine","volume":"102","author":"Ogra","year":"1969","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2004.12.029_bib106","first-page":"83","article-title":"Oral immunization with influenza virus: experimental and clinical studies","volume":"146","author":"Bergman","year":"1989","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2004.12.029_bib107","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0264-410X(90)90047-P","article-title":"Specific immune response in humans following rectal delivery of live typhoid vaccine","volume":"8","author":"Forrest","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.12.029_bib108","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1128\/IAI.69.6.4125-4128.2001","article-title":"Local and systemic immune responses to rectal administration of recombinant cholera toxin B-subunit in humans","author":"Jertborn","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.12.029_bib109","series-title":"Proceedings of the Seventh International Congress Mucosal Immunology","first-page":"170","article-title":"Oral immunization against respiratory viruses in mice","author":"Nedrud","year":"1992"},{"key":"10.1016\/j.vaccine.2004.12.029_bib110","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1128\/iai.30.2.427-430.1980","article-title":"Different secretory Immunoglobulin A antibody responses to cholera vaccination in Swedish and Pakistani women","volume":"30","author":"Svennerholm","year":"1980","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.12.029_bib111","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/IAI.60.2.465-471.1992","article-title":"Effect of parental immunization on the intestinal immune response to Salmonella typhi Ty21a","volume":"60","author":"Forrest","year":"1992","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.12.029_bib112","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1128\/IAI.56.4.910-915.1988","article-title":"Combined parenteral and oral immunization results in an enhanced mucosal immunoglobulin A response to Shigella flexneri","volume":"56","author":"Keren","year":"1988","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.12.029_bib113","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1128\/IAI.65.6.2107-2111.1997","article-title":"Comparison of alternative buffers for use with a new live oral cholera vaccine, Peru-15, in outpatient volunteers","volume":"65","author":"Sack","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.12.029_bib114","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/infdis\/154.1.175","article-title":"Effect of neutralization of gastric acid on immune responses to an oral B-subunit, killed whole cell cholera vaccine","volume":"154","author":"Clemens","year":"1986","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2004.12.029_bib115","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1177\/096805199600300606","article-title":"Oral administration of Escherichia coli in enteric coated microparticles induces serum antibodies against lipopolysaccharide antigens","volume":"3","author":"Flanagan","year":"1996","journal-title":"J Endotoxin Res"},{"issue":"8720","key":"10.1016\/j.vaccine.2004.12.029_bib116","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0140-6736(90)92266-K","article-title":"Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomized controlled field trial","volume":"336","author":"Levine","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2004.12.029_bib117","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/infdis\/148.2.292","article-title":"Epidemiologic and clinical features of endemic campylobacter jejuni infection in Bangladesh","volume":"148","author":"Glass","year":"1983","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2004.12.029_bib118","series-title":"Campylobacter III","first-page":"129","article-title":"Immunity to Campylobacter jejuni in man","author":"Black","year":"1985"},{"key":"10.1016\/j.vaccine.2004.12.029_bib119","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1128\/IAI.57.8.2542-2546.1989","article-title":"Immune response to Campylobacter jejuni and Campylobacter coli in a cohort of children form birth to 2 years of age","volume":"57","author":"Martin","year":"1989","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.12.029_bib120","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/infdis\/157.3.472","article-title":"Experimental Campylobacter jejuni infection in humans","volume":"157","author":"Black","year":"1988","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2004.12.029_bib121","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1128\/IAI.55.6.1431-1435.1987","article-title":"Intestinal mucus gel and secretory antibody are barriers to Campylobacter jejuni adherence to INT 407 cells","volume":"55","author":"McSweegan","year":"1987","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.12.029_bib122","doi-asserted-by":"crossref","first-page":"832","DOI":"10.7326\/0003-4819-100-6-832","article-title":"Persistant Campylobacter jejuni infection in an immunocompromised patient","volume":"100","author":"Johnson","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2004.12.029_bib123","first-page":"752","article-title":"Campylobacter enteritis in normal and deficient children","volume":"1371","author":"Melamed","year":"1983","journal-title":"Am J Dis Child"},{"issue":"2","key":"10.1016\/j.vaccine.2004.12.029_bib124","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1128\/IAI.43.2.739-743.1984","article-title":"Human antibody response to outer membrane proteins of Campylobacter jejuni during infection","volume":"43","author":"Mills","year":"1984","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.12.029_bib125","first-page":"1201","article-title":"The identification of outer membrane proteins and flagella of Campylobacter jejuni","volume":"130","author":"Newell","year":"1984","journal-title":"J Gen Microbiol"},{"issue":"8","key":"10.1016\/j.vaccine.2004.12.029_bib126","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1128\/IAI.67.8.4171-4182.1999","article-title":"Campylobacter jejuni 81-176 associates with microtubules and dynein during invasion of human intestinal cells","volume":"67","author":"Hu","year":"1999","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2004.12.029_bib127","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1128\/IAI.61.5.1764-1771.1993","article-title":"Role of flagella adherence, internalization, and translocation of Campylobacter jejuni in nonpolarized and polarized epithelial cell cultures","volume":"61","author":"Grant","year":"1993","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2004.12.029_bib128","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1128\/jb.168.2.739-745.1986","article-title":"Location of epitopes on Campylobacter jejuni flagella","volume":"168","author":"Logan","year":"1986","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2004.12.029_bib129","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1128\/jb.176.11.3303-3313.1994","article-title":"Structural and antigenic characteristics of Campylobacter coli FlaA flagellin","volume":"176","author":"Power","year":"1994","journal-title":"J Bacteriol"},{"issue":"3","key":"10.1016\/j.vaccine.2004.12.029_bib130","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1128\/IAI.38.3.898-906.1982","article-title":"Outer membrane characteristics of Campylobacter jejuni","volume":"38","author":"Logan","year":"1982","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2004.12.029_bib131","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1128\/IAI.43.3.986-993.1984","article-title":"Campylobacter jejuni outer membrane proteins are antigenic for humans","volume":"43","author":"Blaser","year":"1984","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.12.029_bib132","doi-asserted-by":"crossref","unstructured":"Pei ZH, Ellison RT, 3rd, Blaser MJ. Identification, purification, and characterization of major antigenic proteins of Campylobacter jejuni. J Biol Chem 1991;266925:16363\u20139.","DOI":"10.1016\/S0021-9258(18)55306-0"},{"key":"10.1016\/j.vaccine.2004.12.029_bib133","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1128\/JCM.15.5.761-768.1982","article-title":"Serotyping of Campylobacter jejuni by slide agglutination based on heat-labile antigenic factors","volume":"15","author":"Lior","year":"1982","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2004.12.029_bib134","series-title":"Adjuvants\u2014theory and practical applications","first-page":"337","article-title":"Escherichia coli heat-labile enterotoxin, an oral adjuvant for protection against mucosal pathogens","author":"Majde","year":"1995"},{"issue":"1","key":"10.1016\/j.vaccine.2004.12.029_bib135","first-page":"1","article-title":"Use of heat-labile toxin of enterotoxigenic Escherichia coli to facilitate mucosal immunization","volume":"2","author":"Walker","year":"1993","journal-title":"Vaccine Res"},{"key":"10.1016\/j.vaccine.2004.12.029_bib136","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1128\/IAI.59.7.2259-2264.1991","article-title":"Significance of flagella in colonization resistance of rabbits immunized with Campylobacter spp","volume":"59","author":"Pavlovskis","year":"1991","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2004.12.029_bib137","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1128\/IAI.63.5.1617-1623.1995","article-title":"Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity","volume":"63","author":"Dickinson","year":"1995","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2004.12.029_bib138","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.1128\/IAI.67.11.5799-5805.1999","article-title":"Evaluation of a truncated recombinant flagellin subunit vaccine against Campylobacter jejuni","volume":"67","author":"Lee","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.12.029_bib139","first-page":"597","article-title":"The humoral antibody response to Shigella dysenteriae type 1 infection, as determined by ELISA","volume":"62","author":"Lindberg","year":"1984","journal-title":"Bull WHO"},{"key":"10.1016\/j.vaccine.2004.12.029_bib140","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0888-0786(88)90043-1","article-title":"Shigella flexneri O-antigen specific enzyme immunoassay; class-specific antibody titres against lipopolysaccharide antigen in adult Swedes with bacillary dysentery","volume":"2","author":"Ekwall","year":"1988","journal-title":"Serodiag Immunother Infect Dis"},{"key":"10.1016\/j.vaccine.2004.12.029_bib141","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0888-0786(88)90036-4","article-title":"Shigella flexneri O-antigen specific immunoassay: class-specific antibody titres against lipopolysaccharide antigens in healthy Vietnamese and Swedish populations","volume":"2","author":"Ekwall","year":"1988","journal-title":"Serodiagn Immunother"},{"key":"10.1016\/j.vaccine.2004.12.029_bib142","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0888-0786(88)90052-2","article-title":"Shigella flexneri O-antigen specific enzyme immunoassay; a prospective study of class-specific antibody titres against lipopolysaccharide antigens in Vietnamese children and adults with serotype 1b and 2a dysentery","volume":"2","author":"Ekwall","year":"1988","journal-title":"Serodiagn Immunother"},{"key":"10.1016\/j.vaccine.2004.12.029_bib143","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/IAI.53.1.57-63.1986","article-title":"Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp","volume":"53","author":"Oaks","year":"1986","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.12.029_bib144","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1128\/IAI.59.7.2341-2350.1991","article-title":"Prospective study of systemic and mucosal immune response in dysenteric patients to specific Shigella invasion plasmid antigens and lipopolysaccharides","volume":"59","author":"Oberhelman","year":"1981","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.12.029_bib145","first-page":"375","article-title":"Studies on vaccination against bacillary dysentery. 4. Oral immunization with live monotypic and combined vaccines","volume":"39","author":"Mel","year":"1968","journal-title":"Bull WHO"},{"key":"10.1016\/j.vaccine.2004.12.029_bib146","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/infdis\/125.1.5","article-title":"Immunity in shigellosis. I. Response of man to attenuated strains of Shigella","volume":"125","author":"DuPont","year":"1972","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2004.12.029_bib147","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.4049\/jimmunol.125.6.2778","article-title":"Antibody-dependent cell-mediated antibacterial activity; K lymphocytes, monocytes, and granulocytes are effective against Shigella","volume":"125","author":"Lowell","year":"1980","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2004.12.029_bib148","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1128\/IAI.64.4.1190-1196.1996","article-title":"Induction of local anti-IpaC antibody response in mice by use of a Shigella flexneri 2a vaccine candidate; implications for use of IpaC as a protein carrier","volume":"64","author":"Barzu","year":"1996","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2004.12.029_bib149","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/IAI.67.7.3437-3443.1999","article-title":"Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602","volume":"67","author":"Coster","year":"1999","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2004.12.029_bib150","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2958.1993.tb01115.x","article-title":"Molecular cloning and characterization of the genetic determinants that express the complete Shigella serotype D (Shigella sonnei) lipopolysaccharide in heterologous live attenuated vaccine strains","volume":"7","author":"Viret","year":"1993","journal-title":"Mol Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2004.12.029_bib151","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1046\/j.1365-2958.1996.435967.x","article-title":"Expression of Shigella sonnei lopopolysaccharide in Vibrio cholerae","volume":"19","author":"Viret","year":"1996","journal-title":"Mol Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2004.12.029_bib152","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1128\/IAI.64.2.576-584.1996","article-title":"Development of Shigella sonnei live oral vaccines based on defined rfbInaba deletion mutants of Vibrio cholerae expressing the Shigella D O polysaccharide","volume":"64","author":"Favre","year":"1996","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2004.12.029_bib153","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1128\/IAI.70.8.4414-4423.2002","article-title":"Molecular cloning and characterization of genes for Shigella sonnei form I O polysaccharide: proposed biosynthetic pathway and stable expression in a live salmonella vaccine vector","volume":"70","author":"Xu","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.12.029_bib154","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1128\/IAI.31.3.1193-1202.1981","article-title":"Role of antigen form in development of mucosal immunoglobulin A response to Shigella flexneri antigens","volume":"31","author":"Keren","year":"1981","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.12.029_bib155","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1586\/14760584.2.2.285","article-title":"Mutants of the Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines","volume":"2","author":"Peppoloni","year":"2003","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2004.12.029_bib156","unstructured":"McKenzie R, Nabors GS, Carpenter C, Gomes G, Forbes E, Liss A, et al. Safety and immunogenicity of an oral, inactivated, whole cell vaccine for Shigella sonnei (SsWC). Sixth Ann Conf Vaccine Res 2004;S8:41."},{"issue":"7","key":"10.1016\/j.vaccine.2004.12.029_bib157","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1128\/IAI.66.7.3311-3316.1998","article-title":"Intestinal immune responses to an inactivated oral enterotoxigenic Escherichia coli vaccine and associated immunoglobulin A responses in blood","volume":"66","author":"Ahren","year":"1998","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2004.12.029_bib158","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1128\/IAI.58.2.341-346.1990","article-title":"Roles of different coli surface antigens of colonization factor antigen II in colonization by and protective immunogenicity of enterotoxigenic Escherichia coli in rabbits","volume":"58","author":"Svennerholm","year":"1990","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.12.029_bib159","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/infdis\/158.2.372","article-title":"Cross-protection by B-subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial","volume":"158","author":"Clemens","year":"1988","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2004.12.029_bib160","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0264-410X(97)00169-2","article-title":"Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli vaccine","volume":"16","author":"Jertborn","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.12.029_bib161","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1086\/314543","article-title":"Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B-subunit vaccine: results of the initial evaluation in children","volume":"179","author":"Savarino","year":"1999","journal-title":"J Infect Dis"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2004.12.029_bib162","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0264-410X(02)00611-4","article-title":"Immune responses elicited against multiple enterotoxigenic Escherichia coli fimbriae and mutant LT expresses in attenuated Shigella vaccine strains","volume":"17","author":"Barry","year":"2003","journal-title":"Vaccinedkjdot"},{"issue":"5","key":"10.1016\/j.vaccine.2004.12.029_bib163","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1128\/IAI.69.5.3150-3158.2001","article-title":"Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enteroxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection","volume":"69","author":"Altboum","year":"2001","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2004.12.029_bib164","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1128\/IAI.71.3.1352-1360.2003","article-title":"Genetic characterization and immunogenicity of coli surface antigen 4 from enterotoxigenic Escherichia coli when it is expressed in a Shigella live-vector strain","volume":"71","author":"Altboum","year":"2003","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2004.12.029_bib165","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1128\/IAI.68.9.4884-4892.2000","article-title":"Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli","volume":"68","author":"Koprowski","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.12.029_bib166","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1128\/IAI.64.1.23-27.1996","article-title":"Further characterization of aroA virG Shigella, flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli","volume":"64","author":"Noriega","year":"1996","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2004.12.029_bib167","doi-asserted-by":"crossref","first-page":"49669","DOI":"10.1128\/IAI.69.8.4969-4979.2001","article-title":"Construction and characterization of genetically defined aro omp mutants of enterotoxigenic Escherichia coli and premliminary studies of safety and immunogenicity in humans","volume":"69","author":"Turner","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.12.029_bib168","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1128\/MMBR.47.4.510-550.1983","article-title":"New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development","volume":"47","author":"Levine","year":"1983","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.vaccine.2004.12.029_bib169","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/infdis\/166.5.1029","article-title":"Evidence that inactivated oral cholera vaccines both prevent and mitigate Vibrio cholerae 01 infections in a cholera-endemic area","volume":"166","author":"Clemens","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2004.12.029_bib170","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/infdis\/164.2.407","article-title":"Antibody responses after immunization with killed oral cholera vaccines during the 1985 vaccine field trial in Bangladesh","volume":"164","author":"Sack","year":"1991","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2004.12.029_bib171","doi-asserted-by":"crossref","first-page":"5990","DOI":"10.1128\/IAI.70.11.5990-5996.2002","article-title":"Role of Vibrio cholerae O139 surface polysaccharides in intestinal colonization","volume":"70","author":"Nesper","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.12.029_bib172","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/infdis\/169.1.230","article-title":"Lack of cross-protection against diarrhea due to Vibrio cholerae O139 (Bengal strain) after oral immunization of rabbits with V. cholerae O1 vaccine strain CVD103-HgR","volume":"169","author":"Albert","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2004.12.029_bib173","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1128\/CDLI.2.6.685-688.1995","article-title":"Comparison of the vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1","volume":"l2","author":"Qadri","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2004.12.029_bib174","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1128\/IAI.65.9.3571-3576.1997","article-title":"Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1","volume":"65","author":"Qadri","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.12.029_bib175","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1128\/IAI.13.3.735-740.1976","article-title":"Synergistic protective effect rabbits immunization with Vibrio cholerae lipopolysaccahride and toxin\/toxoid","volume":"13","author":"Svennerholm","year":"1976","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.12.029_bib176","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1128\/IAI.55.5.1116-1120.1987","article-title":"Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B-subunit of cholera toxin","volume":"55","author":"Black","year":"1987","journal-title":"Infect Immun"},{"issue":"8684","key":"10.1016\/j.vaccine.2004.12.029_bib177","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0140-6736(90)90080-O","article-title":"Field trial of oral cholera vaccines in Bangladesh: results of a three-year follow-up","volume":"335","author":"Clemens","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2004.12.029_bib178","first-page":"2","article-title":"Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam","volume":"80","author":"Trach","year":"2002","journal-title":"Bull WHO"},{"key":"10.1016\/j.vaccine.2004.12.029_bib179","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0140-6736(96)06107-7","article-title":"Field trial of a locally produced, killed oral cholera vaccine in Vietnam","volume":"349","author":"Trach","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2004.12.029_bib180","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1128\/IAI.57.11.3261-3264.1989","article-title":"Preliminary assessment of the safety and immunogenicity of live oral cholera vaccine strain CVD 103-HgR in healthy Thai adults","volume":"57","author":"Migasena","year":"1989","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2004.12.029_bib181","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0264-410X(98)00441-1","article-title":"Killed whole bacterial cells, a mucosal delivery system for the induction of immunity in the respiratory tract and middle ear: an overview","volume":"17","author":"Kyd","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.12.029_bib182","doi-asserted-by":"crossref","unstructured":"Foxwell AR, Cripps AW, Dear, KB. Haemophilus influenzae oral whole cell vaccination for prevention of acute exacerbations of chronic bronchitis. Cochrane Database Sys Rev 2003;3:CD001958.","DOI":"10.1002\/14651858.CD001958"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0500191X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0500191X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T06:55:49Z","timestamp":1683010549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X0500191X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":182,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0264410X0500191X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.12.029","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}